Tag Archives: 436 patients consisting of 836 patients in a fully cross-validated training group and independent testing group of 600 patients. The study describes the

Dr. Laurence Klotz M.D., FRCSC, CM, the Chief Medical Officer of miR Scientific LLC, presents the results of the recently completed Case-Control validation study of 1,436 patients consisting of 836 patients in a fully cross-validated training group and independent testing group of ...

Read More »